bpc 157 human studies randomized clinical trial If BPC-157 worked as well as the internet says it does… …we'd probably have high quality trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of BPC-157 Explained: Potential Benefits, Risks,
Description
For thyroid function specifically, this matters enormously
Preprint at arXiv (2021)
Retatrutide : This triple agonist (GLP-1 + GIP + glucagon) produced 28.7% weight loss in Phase 3 but introduced a new safety signal: dysesthesia (abnormal skin sensations) in 4.4 to 20.9% of participants at the 12 mg dose depending on trial population
Understand limitations: Animal studies don't always translate to humans Recognize context: Guests may have commercial interests in products they discuss This article attempts to do exactly that: separate what Rogan has said from what the published science supports
